MDT - Medtronic plc
| Previous Close | 90.37 |
| Open | 94.87 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 800 |
| Day's Range | 91.33 - 94.89 |
| 52 Week Range | 76.41 - 100.15 |
| Volume | 8,270,822 |
| Avg. Volume | 5,231,416 |
| Market Cap | 124.463B |
| Beta (3Y Monthly) | 0.63 |
| PE Ratio (TTM) | 39.74 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.00 (2.12%) |
| Ex-Dividend Date | 2018-09-27 |
| 1y Target Est | N/A |
- Thomson Reuters StreetEvents•51 minutes ago
Edited Transcript of MDT earnings conference call or presentation 20-Nov-18 1:00pm GMT
Q2 2019 Medtronic PLC Earnings Call
Motley Fool•11 hours agoMedtronic plc (MDT) Q2 2019 Earnings Conference Call Transcript
MDT earnings call for the period ending October 31, 2018.
- Zacks•12 hours ago
Medtronic (MDT) Tops Q2 Earnings on Strong Segmental Growth
Medtronic (MDT) demonstrated improved performances at CER on growth in all business segments. However, costs continue to escalate.
- Investing.com•15 hours ago
Medtronic Rises 4%
Investing.com - Medtronic (NYSE:MDT) rose by 4.19% to trade at $94.16 by 09:30 (14:30 GMT) on Tuesday on the NYSE exchange.
- Reuters•16 hours ago
Medtronic sets rosy outlook on strong cardiac, surgical product sales
Medical device maker Medtronic Plc on Tuesday beat analysts' profit estimates for the second quarter and boosted its annual revenue growth outlook, driven by robust sales at its cardiac and surgical product units, sending its shares up 3 percent. Sales at the unit rose 26 percent helped by the strong adoption of MiniMed 670G system in the United States. Medtronic's MiniMed 670G "artificial pancreas" is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes.
- Investing.com•18 hours ago
Medtronic Earnings, Revenue beat in Q2
Investing.com - Medtronic (NYSE:MDT) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
- Zacks•18 hours ago
Medtronic Moves a Step Ahead With Mazor Robotics Buyout
Medtronic's (MDT) resolve to take over the Israel-based robotic surgical guidance systems company, Mazor Robotics, adheres to its goal to grow in the sphere of robotics spine surgery.
- Zacks•18 hours ago
Medtronic (MDT) Tops Q2 Earnings and Revenue Estimates
Medtronic (MDT) delivered earnings and revenue surprises of 7.02% and 1.77%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
- Benzinga•18 hours ago
The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 19) Merck & Co., Inc. (NYSE: MRK ) Down In The Dumps (Biotech ...
- CNBC•19 hours ago
Stocks making the biggest move premarket: TGT, BBY, KSS, LOW, MDT & more
Check out the companies making headlines before the bell: Target TGT – The retailer earned an adjusted $1.09 per share for the third quarter , 3 cents a share below estimates. Revenue exceeded forecasts, however, and comparable-store sales were up 5.
- MarketWatch•19 hours ago
Medtronic reports Q2 profit, revenue beats
Medtronic PLC reported second-quarter profit and revenue beats early Tuesday, but also said it has taken hits from foreign exchange rates and projected China tariffs. Company shares slumped 0.2% in premarket trade. Earnings for the latest quarter declined to $1.115 billion, or 82 cents per share, from $2.017 billion, or $1.48 per share in the year-earlier period. Adjusted earnings-per-share were $1.22, above the FactSet consensus of $1.15. Revenue rose to $7.481 billion from $7.050 billion, above the FactSet consensus of $7.348 billion. The company said that if exchange rates hold for the rest of the fiscal year, fiscal 2019 revenue would be negatively affected by roughly $420 million to $520 million. Medtronic also said that "operational outperformance" in the first half of fiscal year 2019 had allowed the company to absorb expenses like foreign exchange impacts and the projected impacts of China tariffs. It continues to expect fiscal year 2019 adjusted EPS of $5.10 to $5.15, compared with the FactSet consensus of $5.12. Medtronic shares have lifted 0.4% over the last three months, compared with a 5.8% decline in the S&P 500 and a 2.9% decline in the Dow Jones Industrial Average .
- Simply Wall St.•20 hours ago
Should You Be Pleased About The CEO Pay At Medtronic plc’s (NYSE:MDT)
Omar Ishrak became the CEO of Medtronic plc (NYSE:MDT) in 2011. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. After Read More...
- Associated Press•20 hours ago
Medtronic: Fiscal 2Q Earnings Snapshot
On a per-share basis, the Dublin-based company said it had net income of 82 cents. Earnings, adjusted for amortization costs and restructuring costs, came to $1.22 per share. The results surpassed Wall ...
- Reuters•20 hours ago
Medtronic reports 6 pct rise in quarterly revenue
Medical device maker Medtronic Plc reported a 6 percent rise in quarterly revenue on Tuesday, helped by higher sales in its cardiac and vascular business. Net income attributable to the company fell to ...
- Investing.com•2 days ago
Medtronic Falls 3%
Investing.com - Medtronic (NYSE:MDT) fell by 3.19% to trade at $90.71 by 11:51 (16:51 GMT) on Monday on the NYSE exchange.
- Benzinga•2 days ago
Medtronic's Q2 Earnings Preview
Medtronic, Inc. (NYSE: MDT ) announces its next round of earnings this Tuesday, Nov. 20. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Based on ...
- Zacks•2 days ago
Will Diabetes Arm Aid Medtronic's (MDT) Q2 Earnings Again?
Medtronic (MDT) gains traction from the U.S. launch of its Guardian Connect product. This enables the company to further capture a considerable share in the $1-billion standalone CGM market.
- CNBC•4 days ago
Cramer's game plan: Focus on opportunity as market awaits Fed, China news
The "Mad Money" host will be watching for include key housing data, as well as news on interest rates and a potential trade deal. CNBC's Jim Cramer will be seeking out "man-made" buying opportunities for investors in the short week before Thanksgiving Day. "Immediately, there were questions about ... the validity or the sincerity of both of these statements," Cramer noted, referencing his own concern about the Fed's lack of rigor in its policymaking.
GuruFocus.com•4 days agoStanley Druckenmiller Sells Facebook, Buys PayPal in 3rd Quarter
Tech enthusiast also ditches Netflix, Alibaba
- Zacks•5 days ago
Will Strong RTG Arm Shape Medtronic's (MDT) Q2 Earnings?
Medtronic (MDT) poised to gain on continued RTG business growth in Q2.
- Zacks•5 days ago
Here's What Will Shape Medtronic's (MDT) Fate in Q2 Earnings
Medtronic (MDT) is expected to maintain a decent market share in the core pacing banking, backed by the continued rollout of Micra Transcatheter Pacing System.
- Zacks•6 days ago
Is Medtronic (MDT) Stock Outpacing Its Medical Peers This Year?
Is (MDT) Outperforming Other Medical Stocks This Year?
- Zacks•8 days ago
Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Motley Fool•9 days ago
Mazor Robotics Marks Time as It Waits to Be Acquired
The company's financial statements took a big step back during the quarter, but all eyes are on the pending Medtronic buyout.
